Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline

Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline - European Society For Medical Oncology (ESMO)

- Cancer-associated thrombosis is a major health problem that affects morbidity and mortality of people with cancer.

- Surgical and systemic pharmacological anticancer treatments have a significant impact on the thrombotic risk of patients.

- Primary thromboprophylaxis may be considered in high-risk ambulatory cancer patients using validated risk models.

- Anticoagulant treatment of VTE in cancer patients is effective but may be associated with increased bleeding.

- LMWH or DOACs are effective treatments and generally safe options for cancer-associated thrombosis.


Read full Guideline